Sökning: onr:"swepub:oai:DiVA.org:uu-137097" >
Immune response to ...
Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients : Results from the EBMT IDWP01 trial
-
Cordonnier, Catherine (författare)
-
Labopin, Myriam (författare)
-
Chesnel, Virginie (författare)
-
visa fler...
-
Ribaud, Patricia (författare)
-
De La Camara, Rafael (författare)
-
Martino, Rodrigo (författare)
-
Ullmann, Andrew J. (författare)
-
Parkkali, Terttu (författare)
-
Locasciulli, Anna (författare)
-
Yakouben, Karima (författare)
-
- Pauksens, Karlis (författare)
- Uppsala universitet,Infektionssjukdomar
-
Bonnet, Eric (författare)
-
Einsele, Hermann (författare)
-
Niederwieser, Dietger (författare)
-
Apperley, Jane (författare)
-
- Ljungman, Per (författare)
- Karolinska Institutet
-
visa färre...
-
(creator_code:org_t)
- Elsevier BV, 2010
- 2010
- Engelska.
-
Ingår i: Vaccine. - : Elsevier BV. - 0264-410X .- 1873-2518. ; 28:15, s. 2730-2734
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- The current recommendations for active immunization after stem cell transplant (SCT) include 3 doses of 7-valent pneumococcal conjugate vaccine (PCV7) from 3 months after transplant, followed by a 23-valent polysaccharide pneumococcal vaccine (PPV23). However, until now, the immune response to PPV23 after PCV7 has not been assessed after SCT. In the EBMT IDWP01 trial, 101 patients received 1 dose of PPV23 at 12 or 18 months, both after 3 doses of PCV7. The efficacy of PPV23 was assessed 1 month later and at 24 months after transplant by the pneumococcal serotype 1 and 5 antibody levels. Serotype 1 and 5 are not included in PCV7. Although the geometric mean concentrations were significantly higher 1 month after PPV23, for both antigens, the response rates (>= 0.15 mu g/mL), in the range of 68-94%, were not different between groups independent of the assessment date. One PPV23 dose after 3 PCV7 doses, already known to increase the response to PCV7, also extends the serotype coverage given 12 or 18 months after transplant. (C) 2010 Elsevier Ltd. All rights reserved.
Nyckelord
- Pneumococcal vaccine
- Pneumococcal infection
- Allogeneic stem cell transplantation
- MEDICINE
- MEDICIN
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
-
Vaccine
(Sök värdpublikationen i LIBRIS)
Till lärosätets databas
- Av författaren/redakt...
-
Cordonnier, Cath ...
-
Labopin, Myriam
-
Chesnel, Virgini ...
-
Ribaud, Patricia
-
De La Camara, Ra ...
-
Martino, Rodrigo
-
visa fler...
-
Ullmann, Andrew ...
-
Parkkali, Terttu
-
Locasciulli, Ann ...
-
Yakouben, Karima
-
Pauksens, Karlis
-
Bonnet, Eric
-
Einsele, Hermann
-
Niederwieser, Di ...
-
Apperley, Jane
-
Ljungman, Per
-
visa färre...
- Artiklar i publikationen
-
Vaccine
- Av lärosätet
-
Uppsala universitet
-
Karolinska Institutet